e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Palliative care in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Symptoms management of advanced lung disease
V. Carrieri-Kohlman (San Francisco, United States Of America)
Source:
Annual Congress 2004 - Palliative care in lung disease
Session:
Palliative care in lung disease
Session type:
Assembly Symposium
Number:
2862
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Carrieri-Kohlman (San Francisco, United States Of America). Symptoms management of advanced lung disease. Annual Congress 2004 - Palliative care in lung disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
When to refer patients with advanced COPD to palliative care services
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Beyond palliative care: tackling the origins of asthma
Related content which might interest you:
The management of GERD in patients with advanced lung disease: drugs or surgery?
Source: Annual Congress 2009 - The role of gastro-oesophageal reflux in advanced lung disease
Year: 2009
Impact of COVID-19 on patients with chronic lung disease
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Transition from treatment to palliation in chronic lung disease
Source: Annual Congress 2006 - PG10 - Preparation and palliation for end-of-life in chronic respiratory disease
Year: 2006
Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016
Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Challenging infections in advanced CF lung disease
Source: Annual Congress 2013 –Challenges in lung transplantation for cystic fibrosis
Year: 2013
Challenges in molecular testing in lung cancer patients with advanced disease
Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management
Year: 2016
Dyspnoea management in end-stage lung disease
Source: Annual Congress 2006 - Improving end-of-life care
Year: 2006
Impact of chronic obstructive pulmonary disease on the recurrence and second tumors of lung cancer after surgical resection
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019
Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Association of caregiver burden and depression in caregivers of patients with chronic respiratory failure secondary to advanced and end stage lung disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
Role of surgical management in oligometastatic disease
Source: International Congress 2019 – New perspectives in thoracic surgical oncology
Year: 2019
Chronic obstructive pulmonary disease as a predictor of lung cancer mortality
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Pulmonary function evaluation in advanced Parkinson‘s disease
Source: Eur Respir J 2006; 28: Suppl. 50, 201s
Year: 2006
Delay in diagnosis of COPD leading to poor prognosis of disease
Source: International Congress 2015 – Different data in COPD
Year: 2015
Psychological outcomes from pulmonary rehabilitation in patients with chronic obstructive lung disease
Source: Annual Congress 2010 - The psychological impact and educational issues of chronic lung disease: could we do more?
Year: 2010
Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept